Loading...
Loading...
Among the 8 tracked institutional investors we monitor, TGTX (TG THERAPEUTICS INC) is held with a combined value of $1.62B across 50,281,235 shares. The largest holder is BlackRock, Inc. with a position worth $739.24M (0.01% of their portfolio). 2 funds opened new positions in the most recent quarter. 4 funds increased their holdings. 2 funds reduced their position.
Total Institutional Value
$1.62B
Total Shares Held
50,281,235
Institutional Holders
8
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $739.24M | 0.01% | +1.9% |
| 2 | VANGUARD GROUP INC | $472.22M | 0.01% | New |
| 3 | STATE STREET CORP | $287.35M | 0.01% | +2.0% |
| 4 | CITADEL ADVISORS LLC | $81.19M | 0.01% | +50.8% |
| 5 | RENAISSANCE TECHNOLOGIES LLC | $11.32M | 0.02% | New |
| 6 | Bridgewater Associates, LP | $10.35M | 0.05% | -33.7% |
| 7 | FMR LLC | $9.32M | 0.00% | +23.5% |
| 8 | MILLENNIUM MANAGEMENT LLC | $5.34M | 0.00% | -76.2% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of TGTX with a position worth $739.24M, representing 0.01% of their portfolio. In total, 8 institutional investors hold TGTX with a combined value of $1.62B.
In the most recent quarter, 2 funds opened a new position in TGTX. Additionally, 4 increased their holdings and 2 reduced their positions.
Institutional investors hold $1.62B worth of TGTX stock across 8 positions. The largest institutional holder is BlackRock, Inc. with $739.24M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For TGTX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their TGTX positions.